COMMUNIQUÉS West-GlobeNewswire

LogicBio Announces Partnership with Children’s Medical Research Institute to Develop Next Generation Viral Vectors
15/11/2018
CAMBRIDGE, Mass., Nov. 15, 2018 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ: LOGC), a genome editing company focused on developing medicines to durably treat rare diseases, today announced the launch of a [...]
State-of-the-Art Cellular System Installed at The Wharf in Washington, D.C.
15/11/2018
Connectivity Wireless Solutions provides future-ready connectivity for District Wharf visitors and residents WASHINGTON, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Developers PN Hoffman and Madison Marquette announce that The [...]
Mesoblast Financial Results Webcast for Quarter Ended September 30, 2018
15/11/2018
NEW YORK and MELBOURNE, Australia, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) will report financial results for the quarter ended September 30, 2018 in a webcast beginning at 4:30 pm on [...]
HealthLynked Reports Third Quarter 2018 Financial Results
15/11/2018
HealthLynked Revenue Increased 19% Year-to-Date Compared to the Same Period in 2017 NAPLES, Fla., Nov. 15, 2018 (GLOBE NEWSWIRE) -- HealthLynked Corp. (OTCQB: HLYK ), a provider of healthcare-related technology which [...]
AC Immune Awarded Third Follow-up Grant from The Michael J. Fox Foundation for First-in-Human Study of a Positron Emission Tomography (PET) Tracer for Parkinson's Disease
15/11/2018
Grant supports next step in development of potentially first alpha-synuclein PET tracer for Parkinson's disease Start of first-in-human study of current lead is scheduled for Q1 2019 Follow-up grant marks longstanding [...]
INNATE PHARMA : Third quarter 2018 report
15/11/2018
Innate Pharma Third quarter 2018 Report Acceleration of becoming a fully integrated oncology-focused biotech company through a recent landmark deal with AstraZeneca Expansion of oncology development collaboration with [...]
INNATE PHARMA : Information financière du troisième trimestre 2018
15/11/2018
Information financiÈre du troisiÈme trimestre 2018 Accélération de la stratégie pour transformer Innate Pharma en une société de biotechnologie intégrée dédiée à l'oncologie grâce à un accord structurant avec [...]
Biocartis Group NV: BIOCARTIS Q3 2018 BUSINESS UPDATE
15/11/2018
PRESS RELEASE : REGULATED INFORMATION Thursday, 15 November 2018, 07:00 CET BIOCARTIS Q3 2018 BUSINESS UPDATE Mechelen, Belgium , 15 November 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative [...]
Interim Report Q3 2018: Continued strong double digit organic revenue growth. 20% organic revenue growth in GN Audio
15/11/2018
GN Store Nord delivered 12% organic revenue growth in Q3 2018. Revenue growth was 12% including around (1)% impact from the development in foreign exchange rates and 1% impact from M&A EBITA margin increased to 18.0 [...]
IBA Press Release : IBA BUSINESS UPDATE - THIRD QUARTER 2018
15/11/2018
IBA Business Update - Third Quarter 2018 Proton Therapy and Other Accelerators projects on track, outlook reiterated Louvain-La-Neuve, Belgium, 15 November 2018 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s [...]
IBA DÉCLARATION INTERMÉDIAIRE – TROISIÈME TRIMESTRE 2018
15/11/2018
IBA Déclaration Intermédiaire – Troisième Trimestre 2018 Les projets de Protonthérapie et Autres Accélérateurs en bonne voie. prévisions de résultats réitérées Louvain-La-Neuve, Belgique, 15 novembre 2018 - IBA (Ion [...]
Kane Biotech Announces Third Quarter 2018 Financial Results
15/11/2018
WINNIPEG, Manitoba, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE, OTCQB:KNBIF) (the “Corporation” or “Kane Biotech”) announces its Third Quarter 2018 Financial Results. Kane Biotech Inc. is a [...]
Neuralstem Reports Third Quarter 2018 Financial Results and Provides Business Update
14/11/2018
- NSI-189 Received Orphan Designation for Treatment of Angelman Syndrome - - Initiated Phase 2 Clinical Trial of NSI-566 for Treatment of Chronic Stroke - - Second-Generation Neural Stem Cell Program NSI-532 Showed [...]
EDAP TMS SA : EDAP Reports 2018 Third Quarter Results
14/11/2018
Generated revenue growth of more than 14% as compared to the third quarter of 2017 Continued geographic expansion of Focal One with installations in Brazil and South Korea Since receiving FDA clearance for Focal One in [...]
Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter of Fiscal Year 2019 Ended September 30, 2018
14/11/2018
GARDNER, Ma., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced operating results on an unaudited basis for its first quarter ended September 30, 2018. [...]
ARCA biopharma Announces Third Quarter 2018 Financial Results and Provides Corporate Update
14/11/2018
WESTMINSTER, Colo., Nov. 14, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
14/11/2018
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today [...]
Vigil Reports Revenue and Earnings Up in Second Quarter
14/11/2018
VICTORIA, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) announces the results of operations for the quarter ending September 30, 2018. Business Highlights Revenue $1.71 [...]
Cytori Reports Q3 2018 Business and Financial Results
14/11/2018
SAN DIEGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced Q3 2018 financial results and provided updates on corporate activities. Q3 2018 net loss was $2 [...]

Pages